Angiodynamics (ANGO) Net Margin (2016 - 2026)
Angiodynamics' Net Margin history spans 17 years, with the latest figure at 10.31% for Q1 2026.
- For Q1 2026, Net Margin fell 419.0% year-over-year to 10.31%; the TTM value through Feb 2026 reached 10.0%, up 461.0%, while the annual FY2025 figure was 11.62%, 4904.0% up from the prior year.
- Net Margin reached 10.31% in Q1 2026 per ANGO's latest filing, down from 7.99% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 58.32% in Q3 2023 to a low of 249.71% in Q1 2024.
- Average Net Margin over 5 years is 23.66%, with a median of 11.75% recorded in 2023.
- Peak YoY movement for Net Margin: crashed -23796bps in 2024, then surged 24359bps in 2025.
- A 5-year view of Net Margin shows it stood at 9.93% in 2022, then plummeted by -270bps to 36.74% in 2023, then surged by 60bps to 14.74% in 2024, then skyrocketed by 46bps to 7.99% in 2025, then decreased by -29bps to 10.31% in 2026.
- Per Business Quant, the three most recent readings for ANGO's Net Margin are 10.31% (Q1 2026), 7.99% (Q4 2025), and 14.4% (Q3 2025).